logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9452159 B1

PDFFull Text
Expired
Date of Patent:
Sep. 27, 2016

Filed:

Dec. 21, 2012

6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis

Applicant:

Research Cooperation Foundation of Yeungnam University, Gyeongsan-si, Gyeongsangbuk-do, KR;

Inventors:

Byeong Seon Jeong, Daegu, KR;

Jung Ae Kim, Daegu, JP;

Dong Guk Kim, Daegu, JP;

You Ra Kang, Gyeongsan-si, KR;

Tae Gyu Nam, Suwon-si, KR;

Assignee:

RESEARCH COOPERATION OF YEUNGNAM UNIVERSITY, Gyeongsan-Si, Gyeongsangbuk-Do, KR;

Attorney:

Revolution IP, PLLC

Primary Examiner:

Andrew D Kosar

Assistant Examiner:

Daniel Carcanague

Int. Cl.
CPC ...
A61P 25/00 (2006.01); A61K 31/4402 (2006.01); C07D 213/74 (2006.01); A61P 29/00 (2006.01); A61K 31/44 (2006.01); A61K 31/4433 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01);
U.S. Cl.
CPC ...
A61K 31/44 (2013.01); A61K 31/444 (2013.01); A61K 31/4433 (2013.01); A61K 31/4439 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); C07D 213/74 (2013.01);
Abstract

A method or composition including 6-aminopyridin-3-ol derivatives or pharmaceutically acceptable salts thereof for treating a disease caused by angiogenesis, the 6-aminopyridin-3-ol derivatives represented by Formula 1 or the pharmaceutically acceptable salts thereof have excellent neoangiogenesis inhibition effects in the chorioallantoic membrane model, and are suitable for use as a drug for the treatment of disease caused by angiogenesis.

Find Patent Forward Citations

Quick Actions:

Jeong, Byeong. (2016). 6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis (U.S. Patent No. 9452159). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9452159

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…